Nexalin Technology Inc Quick Ratio (NXL) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Nexalin Technology Inc   (NASDAQ: NXL)

Nexalin Technology Inc 's Quick Ratio

NXL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 0.29 below Nexalin Technology Inc average.

Within Medical Equipment & Supplies industry 131 other companies have achieved higher Quick Ratio than Nexalin Technology Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 798 to 2340.

Explain Quick Ratio?
How much Cash & cash equivalents NXL´s has?
What are NXL´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/NXL/financial-strength
https://api.csimarket.com/api/v1/companies/NXL/fundamentals
https://api.csimarket.com/api/v1/companies/NXL/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
NXL Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change 672.2 %
Y / Y Cash & cash equivalent Change -81.78 %
Quick Ratio MRQ 0.29
NXL's Total Ranking # 2340
Seq. Current Liabilities Change 85.94 %
Seq. Cash & cash equivalent Change -21.08 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 132
Healthcare Sector # 701
Overall Market # 2340


Quick Ratio Statistics
High Average Low
15.34 5.33 0.32
(Sep 30 2024)   (Dec 31 2021)




Financial Statements
Nexalin Technology Inc 's Current Liabilities $ 3 Millions Visit NXL's Balance sheet
Nexalin Technology Inc 's Cash & cash equivalent $ 1 Millions Visit NXL's Balance sheet
Source of NXL's Sales Visit NXL's Sales by Geography


Cumulative Nexalin Technology Inc 's Quick Ratio

NXL's Quick Ratio for the trailling 12 Months

NXL Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 185.7 %
Y / Y Cash & cash equivalent TTM Growth -47.5 %
Quick Ratio TTM 1.39
Total Ranking TTM # 3960
Seq. Current Liabilities TTM Growth 67.93 %
Seq. Cash & cash equivalent TTM Growth -30.19 %


On the trailing twelve months basis Due to jump in Current Liabilities in the Q3 2026 to $2.76 millions, cumulative Quick Ratio decreased to 1.39 above the NXL average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 201 other companies have achieved higher Quick Ratio than Nexalin Technology Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2820 to 3960.

Explain Quick Ratio?
How much Cash & cash equivalents NXL´s has?
What are NXL´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 202
Healthcare Sector # 894
Within the Market # 3960


trailing twelve months Quick Ratio Statistics
High Average Low
1.42 0.96 0.17
(Sep 30 2024)   (Sep 30 2023)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Qhslab Inc   0.77 $ 0.190  Millions$ 0.247  Millions
Livanova Plc  0.76 $ 563.467  Millions$ 740.193  Millions
West Pharmaceutical Services Inc   0.72 $ 464.100  Millions$ 644.300  Millions
Resmed Inc   0.72 $ 1,010.742  Millions$ 1,406.488  Millions
Electrocore Inc   0.69 $ 7.506  Millions$ 10.866  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.69 $ 8.124  Millions$ 11.778  Millions
Sintx Technologies Inc   0.67 $ 2.005  Millions$ 3.004  Millions
Privia Health Group Inc   0.66 $ 446.283  Millions$ 674.358  Millions
Lensar Inc   0.64 $ 12.622  Millions$ 19.811  Millions
Orthofix Medical Inc   0.62 $ 86.322  Millions$ 138.385  Millions
Carlisle Companies Incorporated  0.62 $ 546.700  Millions$ 880.300  Millions
Align Technology inc   0.57 $ 1,144.931  Millions$ 2,002.010  Millions
Angiodynamics Inc   0.57 $ 33.973  Millions$ 59.689  Millions
Co diagnostics Inc   0.57 $ 1.430  Millions$ 2.512  Millions
Baxter International Inc   0.52 $ 1,976.000  Millions$ 3,809.000  Millions
Infusystem Holdings Inc  0.51 $ 9.108  Millions$ 17.873  Millions
Stryker Corp  0.50 $ 3,271.000  Millions$ 6,500.000  Millions
Msa Safety Inc  0.50 $ 187.248  Millions$ 373.698  Millions
Teleflex Incorporated  0.50 $ 454.065  Millions$ 917.102  Millions
Sonoma Pharmaceuticals Inc   0.46 $ 4.609  Millions$ 9.944  Millions
P3 Health Partners Inc   0.46 $ 43.900  Millions$ 95.593  Millions
Avita Medical Inc   0.46 $ 10.500  Millions$ 23.037  Millions
Alphatec Holdings Inc   0.44 $ 79.936  Millions$ 180.767  Millions
Steris Plc  0.44 $ 531.100  Millions$ 1,207.800  Millions
Sanuwave Health Inc   0.40 $ 6.569  Millions$ 16.394  Millions
Novocure Limited  0.38 $ 102.738  Millions$ 270.659  Millions
Cadre Holdings inc   0.36 $ 63.916  Millions$ 178.051  Millions
U S Physical Therapy Inc  0.35 $ 38.225  Millions$ 109.218  Millions
Tela Bio Inc   0.31 $ 22.664  Millions$ 73.706  Millions
Nexalin Technology Inc   0.29 $ 0.793  Millions$ 2.761  Millions

Date modified: 2026-11-13T04:58:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.